Dr. Agarwal's Health Care Limited
NSE: AGARWALEYE
Prev Close
354.5
Open Price
356.05
Volume
524,935
Today Low / High
354.55 / 370.45
52 WK Low / High
327 / 464
Range
350 - 386
Currently, the stock is trading on the National Stock Exchange (NSE). The stock price stands at 367.9, with a change of 13.4 (3.77997%). The expected target range on the NSE is between 350 - 386. The stock is trending upwards on the NSE, which could present a good opportunity for potential investors.
Dr. Agarwal's Health Care Limited Graph
Dr. Agarwal's Health Care Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Dr. Agarwal's Health Care Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 367.90, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 367.90 | 371.58 | 334.42 - 408.74 |
| 375.26 | 300.21 - 450.31 | ||
| 378.94 | 265.26 - 492.62 | ||
| Bearish Scenario | 367.90 | 364.22 | 327.80 - 400.64 |
| 360.54 | 288.43 - 432.65 | ||
| 356.86 | 249.80 - 463.92 |
Overview of Dr. Agarwal's Health Care Limited
ISIN
INE943P01029
Industry
Medical - Instruments & Supplies
Vol.Avg
429,779
Market Cap
116,314,660,644
Last Dividend
0
Official Website
IPO Date
2025-02-04
DCF Diff
220.62
DCF
147
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 1,422.66 Cr | 788.45 Cr | 634.21 Cr | 0.4458 | 0.00 Cr | 29.08 Cr | 232.73 Cr | 101.69 Cr | 2.70 | 450.07 Cr | 0.0715 |
| 2023-03-31 | 1,016.48 Cr | 559.17 Cr | 457.31 Cr | 0.4499 | 0.00 Cr | 23.42 Cr | 153.55 Cr | 94.10 Cr | 3.06 | 283.86 Cr | 0.0926 |
| 2022-03-31 | 695.27 Cr | 386.15 Cr | 309.12 Cr | 0.4446 | 0.00 Cr | 17.93 Cr | 96.02 Cr | 37.69 Cr | 1.23 | 196.12 Cr | 0.0542 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 111.75 Cr | 2,782.62 Cr | 1,389.49 Cr | 1,347.6370 Cr | 967.88 Cr | 856.13 Cr | 51.90 Cr | 1,145.18 Cr | 0.00 Cr | 0.00 Cr | -440.91 Cr | 414.6920 Cr |
| 2023-03-31 | 126.98 Cr | 1,825.17 Cr | 1,166.10 Cr | 629.5570 Cr | 857.35 Cr | 730.37 Cr | 36.04 Cr | 903.73 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 301.3150 Cr |
| 2022-03-31 | 99.62 Cr | 1,026.13 Cr | 792.31 Cr | 212.3770 Cr | 618.56 Cr | 518.94 Cr | 32.92 Cr | 547.62 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 206.0030 Cr |
| 2021-03-31 | 55.21 Cr | 786.99 Cr | 588.29 Cr | 184.2359 Cr | 468.63 Cr | 413.42 Cr | 27.87 Cr | 452.21 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 150.4396 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 345.9580 Cr | -913.8610 Cr | 552.6710 Cr | 113.6430 Cr | -15.2320 Cr | 111.7490 Cr | -232.3150 Cr | 140.5680 Cr | 29.5490 Cr | -0.7730 Cr | -15.2830 Cr |
| 2023-03-31 | 233.1060 Cr | -509.0850 Cr | 303.3390 Cr | 75.3050 Cr | 27.3600 Cr | 126.9810 Cr | -157.8010 Cr | 83.5910 Cr | 95.1200 Cr | -0.4280 Cr | -2.4920 Cr |
| 2022-03-31 | 164.3280 Cr | -155.3510 Cr | 35.4330 Cr | 93.7400 Cr | 44.4100 Cr | 99.6210 Cr | -70.5880 Cr | 56.7630 Cr | 92.5590 Cr | -0.0070 Cr | -4.6890 Cr |
| 2021-03-31 | 99.1589 Cr | -36.5693 Cr | -37.1071 Cr | -27.3945 Cr | 55.2118 Cr | 55.2118 Cr | -126.5534 Cr | -55.4783 Cr | -16.2772 Cr | 0.0000 Cr | 5.5703 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 430.72 Cr | 242.40 Cr | 188.32 Cr | 0.4372 | 188.32 Cr | 22.34 Cr | 0.73 | 93.76 Cr | 0.0519 |
| 2024-09-30 | 410.03 Cr | 237.18 Cr | 172.86 Cr | 0.4216 | 155.02 Cr | 14.28 Cr | 0.50 | 86.35 Cr | 0.0348 |
| 2024-06-30 | 410.03 Cr | 237.18 Cr | 172.86 Cr | 0.4216 | 155.02 Cr | 14.28 Cr | 0.50 | 86.35 Cr | 0.0348 |
| 2023-12-31 | 332.70 Cr | 191.36 Cr | 141.34 Cr | 0.4248 | 141.34 Cr | 19.81 Cr | 0.71 | 71.80 Cr | 0.0595 |
| 2023-09-30 | 325.29 Cr | 185.48 Cr | 139.81 Cr | 0.4298 | 126.14 Cr | 12.24 Cr | 0.49 | 67.55 Cr | 0.0376 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 490.93 Cr | 0.00 Cr | 0.00 Cr | 490.93 Cr | 0.00 Cr | 0.00 Cr | -1,558.13 Cr |
| 2024-09-30 | 166.76 Cr | 324.17 Cr | 490.93 Cr | 0.00 Cr | 68.71 Cr | 718.92 Cr | 1,311.60 Cr | 3,393.41 Cr | 1,835.28 Cr |
| 2024-06-30 | 166.76 Cr | 324.17 Cr | 490.93 Cr | 110.98 Cr | 68.71 Cr | 718.92 Cr | 1,304.92 Cr | 3,393.41 Cr | 1,835.28 Cr |
| 2024-03-31 | 111.75 Cr | 475.08 Cr | 586.83 Cr | 0.00 Cr | 56.05 Cr | 766.73 Cr | 1,156.08 Cr | 2,782.62 Cr | 1,389.49 Cr |
| 2023-06-30 | 0.00 Cr | 0.00 Cr | 160.64 Cr | 0.00 Cr | 0.00 Cr | 160.64 Cr | 0.00 Cr | 0.00 Cr | -659.07 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 22.34 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 14.28 Cr | 100.99 Cr | -222.00 Cr | 148.51 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -63.45 Cr | 37.54 Cr |
| 2024-06-30 | 14.28 Cr | 100.99 Cr | -222.00 Cr | 148.51 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -63.45 Cr | 37.54 Cr |
| 2023-12-31 | 19.81 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -144.03 Cr | 0.00 Cr | 144.03 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | 12.24 Cr | 96.77 Cr | -398.44 Cr | 310.19 Cr | 144.03 Cr | 144.03 Cr | 0.00 Cr | -57.64 Cr | 39.13 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Instruments & Supplies
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Poly Medicure Limited | POLYMED | ₹2,232.90 | ₹226,250,825,400.00 | ₹227,115.00 |
| Dr. Agarwal's Health Care Limited | AGARWALEYE | ₹367.90 | ₹116,314,660,644.00 | ₹524,935.00 |
| Shaily Engineering Plastics Limited | SHAILY | ₹1,754.00 | ₹80,605,245,400.00 | ₹253,696.00 |
Key Executives
Gender: Not Specified
Year Born: 1983
Gender: male
Year Born: 1986
Gender: Not Specified
Year Born:
Gender: Not Specified
Year Born: 1983
Gender: male
Year Born:
Gender: male
Year Born:
Gender: Not Specified
Year Born: 1984
Gender: Not Specified
Year Born: 1985
FAQs about Dr. Agarwal's Health Care Limited
The CEO is Dr. Adil Agarwal M.B.B.S, M.S, MBA.
The current price is ₹367.90.
The range is ₹327-464.
The market capitalization is ₹11,631.47 crores.
The P/E ratio is 160.02.
The company operates in the Healthcare sector.
Overview of Dr. Agarwal's Health Care Limited (ISIN: INE943P01029) is a leading Medical - Instruments & Supplies in India. With a market capitalization of ₹11,631.47 crores and an average daily volume of 429,779 shares, it operates in the Medical - Instruments & Supplies. The company last declared a dividend of ₹0.